A wound-healing invention developed at the Queensland University of Technology (QUT) has produced remarkable results in an international human trial.
Doctors can now more confidently administer a drug that protects against bacterial superbugs thanks to the development of scientifically-based dosing guidelines for the antibiotic colistin.
The prevalence of self-injury in Australia is substantial and self-injury may begin at older ages than previously reported.
Health professionals face many challenges when healing wounds, and there are many situations where diagnosis and choice of appropriate therapy is not always straightforward.
